Key regions: United Kingdom, Canada, Japan, Europe, China
Turkmenistan, a Central Asian country bordered by the Caspian Sea and largely covered by the Karakum Desert, has seen a steady growth in the dermatological drugs market in recent years.
Customer preferences: Turkmenistan's population has shown a growing interest in dermatological drugs due to an increase in skin-related disorders and diseases. Skin cancer, eczema, psoriasis, and acne are some of the most common skin conditions in the country. The younger population is particularly concerned with maintaining healthy and glowing skin, leading to a surge in demand for dermatological drugs.
Trends in the market: The dermatological drugs market in Turkmenistan is expected to grow in the coming years due to the rising incidence of skin disorders and an ageing population. The market has seen a shift towards natural and organic skincare products, with consumers becoming more aware of the harmful effects of synthetic products. This trend is expected to continue, with companies introducing more natural and organic skincare products in the market.
Local special circumstances: Turkmenistan has a largely underdeveloped healthcare system, with limited access to medical facilities and trained professionals. The government has been investing in the healthcare sector, with a focus on improving access to medical facilities and training healthcare professionals. However, the lack of infrastructure and resources presents a challenge for the dermatological drugs market.
Underlying macroeconomic factors: Turkmenistan's economy is heavily dependent on the oil and gas sector, with the government investing heavily in infrastructure projects to diversify the economy. The country's GDP has been growing steadily, with a focus on developing the non-oil sector. The growth in the dermatological drugs market can be attributed to the overall growth of the healthcare sector in the country.In conclusion, the dermatological drugs market in Turkmenistan is growing due to an increase in skin-related disorders and a growing interest in maintaining healthy skin. The market is expected to continue to grow in the coming years, with a shift towards natural and organic skincare products. However, the lack of infrastructure and resources presents a challenge for the market. The growth in the dermatological drugs market can be attributed to the overall growth of the healthcare sector in the country.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
